KalVista Pharmaceuticals (4XC1.XETRA) Q4 2026 Earnings

3DecConfirmed
Q2 2026
-0.35
-0.02
0.32
0.65

Details

Expected EPS
-0.24765735464000002
Actual EPS
N/A
Surprise EPS
0.25
Surprise Percent
+100%

Description

KalVista Pharmaceuticals (4XC1.XETRA) will report earnings of for Q4 2026 on December 03, 2026.

0 Comments

Share your thoughts